GBA1 and Parkinson disease: Without starvation there was no alteration of LC3-II in Gaucher disease (mean 82 ± 20% of control, P = 0.062), Parkinson’s disease with GBA mutation (mean 88 ± 15% of control, P = 0.13) or non-manifesting carriers (99% of control, P = 0.8).